Cargando…
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
In aggressive pituitary tumors (PT) showing local invasion or growth/recurrence despite multimodal conventional treatment, temozolomide (TMZ) is considered a further therapeutic option, while little data are available on peptide receptor radionuclide therapy (PRRT). We analyzed PRRT effectiveness, s...
Autores principales: | Giuffrida, G, Ferraù, F, Laudicella, R, Cotta, O R, Messina, E, Granata, F, Angileri, F F, Vento, A, Alibrandi, A, Baldari, S, Cannavò, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499924/ https://www.ncbi.nlm.nih.gov/pubmed/30939449 http://dx.doi.org/10.1530/EC-19-0065 |
Ejemplares similares
-
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy
por: Ragonese, M., et al.
Publicado: (2023) -
Multidisciplinary Management of Pituitary Apoplexy
por: Albani, Adriana, et al.
Publicado: (2016) -
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report
por: Giuffrida, Giuseppe, et al.
Publicado: (2021) -
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022) -
The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary
por: Marques, Pedro
Publicado: (2023)